Advanced Solid Tumors: MOMA-313 Oral Medication

We are studying an oral treatment called MOMA-313 for individuals with advanced or metastatic solid tumors. The goal is to learn more about its effects and potential benefits.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Hospital Universitari Vall D Hebron
Servicio de oncologia
Barcelona, Spain
Institut Catala D'oncologia
Servicio de oncologia
L'Hospitalet de Llobregat, Spain
Hospital Universitario Fundacion Jimenez Diaz
Servicio de oncologia
Madrid, Spain
Sponsor: Moma Therapeutics Inc.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.